Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Alagille Syndrome

In brief

Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in Patients with Alagille Syndrome.

Key facts

Study ID
NCT04674761
Run by
Albireo
People needed
52
Starts
2021-03-19
Expected to finish
2022-09-09
Last updated by the study team
2023-11-02

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.